Grey scale echography in the diagnosis of intrahepatic disease.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMID 4209040)

Published in J Clin Ultrasound on December 01, 1973

Authors

K J Taylor, D A Carpenter, V R McCready

Articles by these authors

Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA (1998) 4.76

Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics (1994) 3.74

WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79

Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc Natl Acad Sci U S A (1985) 2.22

Ectopic pregnancy: evaluation with endovaginal color flow imaging. Radiology (1992) 2.10

Blood flow in deep abdominal and pelvic vessels: ultrasonic pulsed-Doppler analysis. Radiology (1985) 2.06

Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73

Ultrasound and scintigraphy in the differential diagnosis of obstructive jaundice. J Clin Ultrasound (1974) 1.70

Effects of ENU dosage on mouse strains. Mamm Genome (2000) 1.69

Lower extremity volumetric arterial blood flow in normal subjects. Ultrasound Med Biol (1998) 1.69

Acute focal bacterial nephritis (acute lobar nephronia). Radiology (1979) 1.64

A strategy for fine-structure functional analysis of a 6- to 11-centimorgan region of mouse chromosome 7 by high-efficiency mutagenesis. Proc Natl Acad Sci U S A (1990) 1.59

FDG accumulation and tumor biology. Nucl Med Biol (1998) 1.59

The potential of intratumoural unsealed radioactive source therapy. Eur J Nucl Med (2001) 1.49

N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: Completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics (1999) 1.46

Future directions for unsealed source radionuclide therapy for bone metastases. Eur J Nucl Med Mol Imaging (2002) 1.45

Timing, magnitude, and utility of surgical delay in the TRAM flap: II. Clinical studies. Plast Reconstr Surg (1997) 1.44

Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42

Assessment tools for the identification of patients at risk for the development of pressure sores: a review. J Enterostomal Ther (1988) 1.41

A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res (2000) 1.39

Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr (1994) 1.38

Intraventricular hemorrhage in the preterm neonate: timing and cerebral blood flow changes. J Pediatr (1984) 1.35

N-ethyl-N-nitrosourea-induced prenatally lethal mutations define at least two complementation groups within the embryonic ectoderm development (eed) locus in mouse chromosome 7. Mamm Genome (1993) 1.29

Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1. Proc Natl Acad Sci U S A (2001) 1.28

Effect of dose fractionation on the ethylnitrosourea induction of specific-locus mutations in mouse spermatogonia. Proc Natl Acad Sci U S A (1982) 1.28

31P-NMR studies of a human tumour in situ. Lancet (1983) 1.27

Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed (1998) 1.27

Transvaginal ultrasonography for the diagnosis of ectopic pregnancy. Fertil Steril (1988) 1.26

Grey-scale ultrasonography in the differential diagnosis of jaundice. Arch Surg (1977) 1.25

Artifacts in ultrasound imaging. J Ultrasound Med (1986) 1.22

Scrotal masses with a uniformly hyperechoic pattern. Radiology (1983) 1.21

Grey-scale ultrasonography for monitoring industrial exposure to hepatotoxic agents. Lancet (1975) 1.21

Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion. Stroke (1999) 1.18

In-vivo 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer. Lancet (1989) 1.18

Direct evidence of cavitation in vivo from diagnostic ultrasound. Ultrasound Med Biol (1996) 1.16

Clinical radioisotope scanning. Br J Radiol (1967) 1.16

Gray scale ultrasound imaging. The anatomy and pathology of the liver. Radiology (1976) 1.15

Accuracy of grey-scale ultrasound diagnosis of abdominal and pelvic abscesses in 220 patients. Lancet (1978) 1.13

Distinct expression patterns of notch family receptors and ligands during development of the mammalian inner ear. Mech Dev (1998) 1.13

CT and sonography in the recognition of mucocele of the appendix. AJR Am J Roentgenol (1984) 1.13

Ultrasonography of alcoholic liver disease with histological correlation. Radiology (1981) 1.13

Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet (1983) 1.12

False positive 131I whole body scans in thyroid cancer. Br J Radiol (2000) 1.11

Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers. Gastroenterology (1990) 1.11

Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol (1984) 1.10

A co-ordinate transfer system for the Pho Gamma 3 Nuclear Chicago gamma camera. Br J Radiol (1969) 1.09

Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology (1996) 1.09

Surgical and pathologic correlation of cholecystosonography and cholecystography. AJR Am J Roentgenol (1978) 1.08

Mechanics of the guinea pig colea. J Acoust Soc Am (1970) 1.07

Congenital absence of the portal vein in oculoauriculovertebral dysplasia (Goldenhar syndrome). Pediatr Radiol (1986) 1.07

Hematopoietic deficiencies in c-mpl and TPO knockout mice. Stem Cells (1998) 1.06

Risk factors for early intraventricular hemorrhage in low birth weight infants. J Pediatr (1992) 1.05

Gray scale ultrasound and isotope scanning: complementary techniques for imaging the liver. AJR Am J Roentgenol (1977) 1.03

Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab (1986) 1.03

Ultrasound Doppler flow studies of the ovarian and uterine arteries. Br J Obstet Gynaecol (1985) 1.02

The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma. Br J Obstet Gynaecol (1989) 1.01

Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion. Stroke (1998) 1.01

Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res (1996) 0.99

The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study. Ann Oncol (1993) 0.99

Deletion mapping of four loci defined by N-ethyl-N-nitrosourea-induced postimplantation-lethal mutations within the pid-Hbb region of mouse chromosome 7. Genetics (1993) 0.99

Combined pancreas and liver scanning using a double isotope technique. Br J Radiol (1971) 0.98

Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother Oncol (1989) 0.98

Pleiotropy in microdeletion syndromes: neurologic and spermatogenic abnormalities in mice homozygous for the p6H deletion are likely due to dysfunction of a single gene. Proc Natl Acad Sci U S A (1995) 0.98

High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. Br J Cancer (2002) 0.98

Monitoring liver disorders in vinyl chloride monomer workers using greyscale ultrasonography. Br J Ind Med (1976) 0.97

Correlation of findings on transvaginal sonography with serum CA 125 levels. AJR Am J Roentgenol (1997) 0.97

Hepatic artery pseudoaneurysm: diagnosis with real-time and pulsed Doppler US. Radiology (1986) 0.97

62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Eur J Nucl Med (2001) 0.96

The mouse scurfy (sf) mutation is tightly linked to Gata1 and Tfe3 on the proximal X chromosome. Mamm Genome (1994) 0.95

The use of ultrasound to enhance the diagnostic utility of the equivocal liver scintigraph. Radiology (1978) 0.95

A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer (1991) 0.95

Phospholipid metabolites, prognosis and proliferation in human breast carcinoma. NMR Biomed (1994) 0.94

The role of ultrasound in the assessment and treatment of abdominal metastases from testicular tumours. Clin Radiol (1977) 0.94

A constant depth ultrasonic scanner. Br J Radiol (1971) 0.94

Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr (1985) 0.94

In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues. Br J Cancer (2010) 0.94

The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med (1998) 0.93

A study of the production of haemorrhagic injury and paraplegia in rat spinal cord by pulsed ultrasound of low megaHertz frequencies in the context of the safety for clinical usage. Br J Radiol (1972) 0.92

Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr (1988) 0.92

Ultrasound examination of pubertal girls and of patients with gonadal dysgenesis. J Adolesc Health Care (1981) 0.92

Benign prognosis of never-symptomatic carotid occlusion. Neurology (2000) 0.92

Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy. Lancet (1983) 0.92

Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. Radiology (1986) 0.91

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma. Br J Cancer (1989) 0.91

Scintigraphic studies of space-occupying liver disease. Semin Nucl Med (1972) 0.91

Genetic and physical mapping of the fitness 1 (fit1) locus within the Fes-Hbb region of mouse chromosome 7. Mamm Genome (1995) 0.91

Diagnostic accuracy of gray scale ultrasongraphy for the jaundiced patient. A report of 275 cases. Arch Intern Med (1979) 0.91

Thyroid cancer: differentiated carcinoma. Cancer Treat Rev (1996) 0.91

A fatality due to the intranasal abuse of methylphenidate (Ritalin). J Forensic Sci (1999) 0.91

The effects of single dose oral hydralazine on blood flow through human lung tumours. Radiother Oncol (1990) 0.91

Physiology of the middle ear transmission system. J Otolaryngol Soc Aust (1971) 0.90

Gray scale ultrasonography in the diagnosis of endometriosis and adenomyosis. AJR Am J Roentgenol (1979) 0.90

Mutations in the murine fitness 1 gene result in defective hematopoiesis. Blood (1997) 0.90

A prognostic system for transient ischemia or minor stroke. Ann Intern Med (1991) 0.90

99mTc-HMPAO as a tumour blood flow agent. Eur J Nucl Med (1987) 0.89

Letter to the editor: Electron diffraction for hydrated crystalline biopolymers: nigeran. J Mol Biol (1975) 0.89